Found: 5
Select item for more details and to access through your institution.
386-P: Chronic Treatment with the Direct AMPK Activator PXL770 Improves Cardiac, Vascular, and Renal Function in Rodents with Diabetes-Related Cardiorenal Disease.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-386-P
- By:
- Publication type:
- Article
1963-P: Short- and Long-Term Empagliflozin Treatment Improves Cardiac Function in Rats with Chronic Heart Failure.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1963-P
- By:
- Publication type:
- Article
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2536, doi. 10.3390/ijms24032536
- By:
- Publication type:
- Article
Acute vasopressin neutralization with the aptamer NOX-F37 improves immediately cardiac but not peripheral endothelial dysfunction in rats with chronic heart failure.
- Published in:
- Artery Research, 2023, v. 29, n. 1, p. S12, doi. 10.1007/s44200-022-00028-8
- By:
- Publication type:
- Article
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 12, p. 1, doi. 10.1161/JAHA.123.032971
- By:
- Publication type:
- Article